QR Code QR Code
Post Offer Free
Nanjing Norman Biological Technology Co., Ltd
Nanjing Norman Biological Technology Co., Ltd  

Gold Index: 24628

You are here: home  > Chemiluminescence Reagents  > Chemiluminescence immunoassay Cardiovascular kits  > chemiluminescence immunoassay Lp-PLA2 test kits

chemiluminescence immunoassay Lp-PLA2 test kits 

Payment Terms: T/T,L/C,D/A,D/P,WU,Paypal,Money Gram 
Place of Origin: Jiangsu, China (Mainland) 
inquire
Add to My Favorites
HiSupplier Escrow
Share |

Product Detail

Model No.: NORMAN 411
Production Capacity: 1,000,000.00/Month
Delivery Date: Two weeks after payment
Methodology: Chemiluminescence immunoass...
Service: OEM/ODM
Type: Manufacturer
Means of Transport: Ocean,Air
Packing: IN CARTON
Brand Name: Norman Biotechnology
Model Number: NORMAN 411
Place of Origin: Jiangsu, China (Mainland)
Delivery Detail: Depend on quantity

Specific markers of cardiovascular inflammation, evaluating indicatorofatheromatous
plaque stability.

                            chemiluminescence immunoassay 

                                     Lp-PLA2 rapid test kits


Product Name                                                                              


Lp-PLA2 

Specific markers of cardiovascular inflammation,evaluating indicatorofatheromatous plaque

stability, independent risk factor for cardiovascular events,assist to guide clinical treatment 

for  cardiovascular patients.


Product Size                                                                                 


Quantity:50 pcs /box  or 100 pcs/box 

Size:11cm x 6cm x 8cm


Clinical Background                                                                  

Coronary artery disease is associated with the severity of atherosclerosis, which is an 

inflammatory disease. 

But although helpful for guiding treatment and improving prognosis, standard 

approaches for assessing a person's risk do not include inflammatory markers.


1.So, individuals with a moderate risk, as determined by standard approaches, 

may actually be at greater risk of a myocardial infarction or stroke than predicted.


2. High-sensitivity C-reactive protein (hs-CRP) is a marker of systemic inflammation 

that can improve risk stratification; however, it is not specific for cardiovascular disease. 

On the other hand, lipoprotein-associated phospholipase A2 (Lp-PLA2) is a specific

 marker of vascular inflammation associated with atherosclerosis.


3.Following production by inflammatory cells, this enzyme cleaves oxidized 

phospholipids, generating pro-inflammatory molecules and oxidized fatty acids.



Individuals Suitable for Testing                                           

1.Individuals with moderate risk of cardiovascular disease (≥2 risk factors and 

Framingham 10-year risk score ≤20%);


2.Individuals with high risk of cardiovascular disease (Framingham 10-year risk 

score >20%)

Individuals with coronary artery disease or risk equivalents (ie, symptomatic

carotid artery disease, peripheral artery disease, abdominal aortic aneurysm, 

diabetes mellitus);


3.Individuals with moderate risk of stroke.


Applicable Department                                                           

Neurology, cardiology, endocrinology, Geriatrics, Department of physical examination;

 

Small necrotic lipid pool, thick fiber cap, high collagen, low Lp-pla2 content (dark stain), 

vascular cavity, benign plaque, light inflammation;

 

big necrotic lipid pool, thin fiber cap, low collagen, high lp-pla2 content (dark stain), 

vascular cavity, thrombus,Malignant plaque,severeinflammation;

 

A2 has better vascular inflammation specificity compare with hs-CRP and LDL.


Product Show                                                                              


Package & Delivery                                                                    


About Us                                                                                        


                                           Company Profile

Nanjing Norman Biological Technology Co., Ltd is dedicated to R&D and manufacturing 

of automated chemiluminescence system. Founded in 2008, Norman biological has been 

upholding the idea that R&D shapes future ,and concentration determines success. 

Ever since the beginning, Norman has been focusing on developing and manufacturing 

chemiluminescence instruments and reagents.


Norman's manufacture center is located in the Yuhua District and owns an 

over 2,000m2 GMP-approved clean workshop. The R&D base, which is  over 2,000m2,

 is located in state-level new Jiangbei district. Now there are over 100 R&D engineers,

40% of which hold a PhD or master's degree.


Being an expert in automated chemiluminescence analysis , Norman owns  independent 

and completed intellectual property rights, and its products provide top-notch 

sensitivity, precision and accuracy . Thanks to the self-developed

antigens and self-manufactured antibodies, Norman's products features minimized

intra-and inter- batch difference.


After 8 years development, Norman is now on the fast track. An over 30,000m2 global 

R&D center is in construction, and will hold more than 1,000 R&D engineers in the future.


Norman News                                                                              

The British general consul stationed in Shanghai lead foreig

In order to promote international technology transfer and cooperation, strengthen the effective 

docking between high-tech enterprises and the British innovation resources , facilitate 

more overseas advanced technology which meet the needs of development of local 

industry to  land in Nanjing and realize industrialization, In the afternoon of March 23 ,

the leaders of high-tech district and British general consul stationed in Shanghai led 

foreign entrepreneurs to visit Norman, president of Norman and other leadership 

provided the visitors warm reception.

Foreign entrepreneurs delegation first visited our office management area, knew about 

Norman core organization structure and function. Subsequently the delegation went to 

R&D center for exchanging. Responsible person of R & D Center introduced the 

development process of our products in detail to the members of the delegation. 

Norman adheres to the independent research and development production of antigen 

and antibody, this attitude let delegation feel deeply Norman's strong R & D strength 

and spirit of rigorous attention. The delegation carefully inquired every items and 

platform, The PCT items contained in chemiluminescence platform, is peripheral 

blood detection, high accuracy, small volume, impressed the delegation and coursed 

them to get great interest.


Related Products                                                                        

Agent Wanted                                                                              


We want to find partners, with whom we can work together stably in long term.  

As a factory, we can offer support in both price and technical service. 

If you are interested in working with us, please feel free to contact. We are eager 

to work with you winning a bright future.


OEM will be highly welcome!

Welcome to our website!


bigPhoto
 Ms. Ying Qin
Department Manager
Tel: 86-25-58602219
Mobile: 138 1471 7578
Contact to this supplier

Didn't find what you're looking for? Post Buying Lead or contact HiSupplier Customer Service Center  for help!

Related Search

Find more related products in following catalogs on Hisupplier.com

Company Info

Nanjing Norman Biological Technology Co., Ltd [China (Mainland)]


Business Type:Manufacturer
City: Nanjing
Province/State: Jiangsu
Country/Region: China (Mainland)

You May Like: